In vivo combination of human anti-envelope glycoprotein E2 and -Claudin-1 monoclonal antibodies for prevention of hepatitis C virus infection

Despite the development of direct-acting antivirals (DAAs), hepatitis C virus (HCV) infection remains a major cause for liver disease and cancer worldwide. Entry inhibitors block virus host cell entry and, therefore, prevent establishment of chronic infection and liver disease. Due to their unique m...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Antiviral Res
Main Authors: Mailly, Laurent, Wrensch, Florian, Heydmann, Laura, Fauvelle, Catherine, Brignon, Nicolas, Zeisel, Mirjam B., Pessaux, Patrick, Keck, Zhen-yong, Schuster, Catherine, Fuerst, Thomas R., Foung, Steven K.H., Baumert, Thomas F.
Formato: Artigo
Idioma:Inglês
Publicado em: 2018
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6463510/
https://ncbi.nlm.nih.gov/pubmed/30599173
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.antiviral.2018.12.018
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados